We report on the use of photonic crystal surfaces as a high-sensitivity platform for detection of a panel of cancer biomarkers in a protein microarray format. The photonic crystal surface is designed to provide an optical resonance at the excitation wavelength of cyanine-5 (Cy5), thus providing an increase in fluorescent intensity for Cy5-labeled analytes measured with a confocal microarray scanner, compared to a glass surface. The sandwich enzyme linked immunosorbent assay is undertaken on a microarray platform to undertake a simultaneous, multiplex analysis of 24 antigens on a single chip. Our results show that the resonant excitation effect increases the signal-to-noise ratio by 3.8- to 6.6-fold, resulting in a decrease in detection limits of 5-90%, with the exact enhancement dependent upon the antibody-antigen interaction. Dose-response characterization of the photonic crystal antibody microarrays shows the capability to detect common cancer biomarkers in the single-digit pg/ml concentration range within a mixed sample.
Revised: March 28, 2011 |
Published: February 15, 2011
Citation
Huang C., S. George, M. Lu, V. Chaudhey, R. Tan, R.C. Zangar, and B.T. Cunningham. 2011.Application of photonic crystal enhanced fluorescence to cancer biomarker microarrays.Analytical Chemistry 83, no. 4:1425-1430. PNWD-SA-9264. doi:10.1021/ac102989n